Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Randomized Controlled Trial of a CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

NCT05726526 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT05726526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Randomized Controlled Trial of a CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Recruiting
Start date
June 30, 2022
Completion date
March 30, 2028
Enrollment
340 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 5, end stage renal disease